Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003131:Combined Modality Therapy; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008207:Lymphatic Metastasis; D008593:Menopause; D009316:National Institutes of Health (U.S.); D011379:Prognosis; D014481:United States
D006728:Hormones